HOME >> BIOLOGY >> NEWS
Lead-'scrubbing' drug may also improve muscle function in lead-exposed children

CINCINNATI -- University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

Led by Amit Bhattacharya, PhD, the UC team found that children treated with succimer (SUX-sim-er) chelation therapy showed a 19 percent improvement in their ability to perform moving taskssuch as crossing an obstacle or walkingthan those who did not receive treatment.

Chelation (ke-LAY-shun) is a technique, nicknamed scrubbing, in which a drug is administered to seek out and bind to poisonous heavy metals, such as lead or mercury, in the bloodstream. The compound resulting from this binding is then excreted in the urine, essentially cleaning out the dangerous metals.

Succimer (Chermet) is an oral chelating drug approved by the Food and Drug Administration to treat children with extremely elevated blood lead levels (44 to 69 micrograms per deciliter).

The UC team has found that succimer chelation therapy improved static balance by 6 percent.

Lead exposure is a very serious issue, says Bhattacharya, professor of environmental health and lead author of the study, and its important to identify early signs of neuromotor (muscle-function) exposure effectssuch as impaired postural balance or locomotionbefore permanent damage occurs. Our research may help develop control strategies for minimizing exposure to lead at an earlier stage.

The team reports its findings in the May 2007 edition of the journal Neurotoxicology. This is the first study to report that succimer chelation therapy can produce beneficial effects on postural balance and movement in lead-exposed children.

Previous research has shown that succimer chelation therapy can reduce lead levels in the blood, but few scientists have investigated whether it can improve neuromotor a
'"/>

Contact: Amanda Harper
amanda.harper@uc.edu
513-558-4657
University of Cincinnati
24-Apr-2007


Page: 1 2

Related biology news :

1. New test improves detection of liver cancer
2. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
3. Gene expression pattern could lead to improved treatment of pediatric septic shock
4. Additional mammogram readers improve breast cancer detection
5. New role for protein in fat cells may improve understanding of obesity and diabetes
6. Jefferson scientists patent dramatically improves
7. Cardiac patches stimulate regeneration, improve function after heart attack
8. Co-operation between GSF and clinic improves outlook for sarcoma patients
9. EPA foregoes opportunity to improve nanotechnology oversight
10. Biocontrol of invasive water hyacinth contributes to socioeconomic and health improvements in Africa
11. Kansas, Missouri School Board members to explore improvements in science-related education

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... (PRWEB) , ... August 25, ... ... clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex ... enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic ...
(Date:8/21/2020)... Mass. (PRWEB) , ... August 18, 2020 , ... ... approaches to cell therapy, today announced that the U.S. Food and Drug Administration ... of Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19. Approval of ...
(Date:8/12/2020)... SOUTHFIELD, Mich. (PRWEB) , ... August 11, 2020 ... ... Janssen R&D subsidiary based in Princeton, NJ, have entered into license agreements with ... discovery and development. Both Roche and J&J have annual Research and Development ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... ... and diagnostics companies, has announced the placement of Julianne Averill , CPA, ... for leading all financial operations and implementing key business strategies to accelerate Alveo’s ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... available for free its new white paper – Simulated Transport Methodologies. Regulatory ... today’s biologics licensing application (BLA). In response, Modality Solutions shares an explanation ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive ... patients may choose which extremities they would like treated. , Several studies have shown ... At R3 International, umbilical cord tissue is obtained from a lab with a long ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
Breaking Biology Technology:
Cached News: